Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa®) in Sweden

Author: Willis Michael  

Publisher: Adis International

ISSN: 1175-5652

Source: Applied Health Economics and Health Policy, Vol.8, Iss.6, 2010-11, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract